Karyopharm Therapeutics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2023.
  • Karyopharm Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.18M, a 17.6% decline year-over-year.
  • Karyopharm Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $19.7M, a 13% decline year-over-year.
  • Karyopharm Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $21.7M, a 38.7% decline from 2022.
  • Karyopharm Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $35.4M, a 18.9% increase from 2021.
  • Karyopharm Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.8M, a 22% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21.7M -$13.7M -38.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $35.4M +$5.62M +18.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $29.8M +$5.38M +22% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $24.4M +$9.12M +59.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $15.3M -$1.98M -11.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $17.3M -$3.13M -15.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $20.4M -$1.88M -8.43% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $22.3M +$5.23M +30.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $17.1M +$2.82M +19.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $14.2M +$10.5M +276% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $3.79M +$3.13M +480% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $653K +$629K +2621% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $24K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.